Pfizer Inc's (NYSE: PFE) short interest as a percent of float has risen 8.25% since its last report. According to exchange ...
Due to the litigation Pfizer filed Friday and Monday against Metsera, Novo Nordisk and the biotech’s lead shareholder, CEO ...
The bidding war between Pfizer ( PFE) and Novo Nordisk ( NVO) over obesity drug developer Metsera ( MTSR) finally ended over ...
Hosted on MSN
3 Things You Need to Know if You Buy Pfizer Today
Pfizer is a large drugmaker with a strong history of working through difficult periods. The pharmaceutical giant's challenges include facing down an impending patent cliff. Pfizer's dividend payout ...
Novo Nordisk’s CEO won’t comment on whether the Danish company will go even higher in its bidding war for Metsera, but said ...
Cogent Biosciences said its experimental drug, called bezuclastinib, lowered the risk of tumor progression or death by 50% ...
And despite the sales slump in the U.S. this past quarter, Pfizer’s Prevnar dynasty still leads in pediatric pneumococcal vaccination worldwide and among conjugated pneumococcal vaccines for adults in ...
Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback